1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Point of Care (PoC) Diagnostic Devices Market: By Application (Glucose Testing, Cholesterol Testing, Others) End User (Clinics, Hospitals, Others) Technology (Molecular Diagnostics, Non-invasive Technology, Others) & By Geography-Forecast(2015-2020)

Point of Care (PoC) Diagnostic Devices Market: By Application (Glucose Testing, Cholesterol Testing, Others) End User (Clinics, Hospitals, Others) Technology (Molecular Diagnostics, Non-invasive Technology, Others) & By Geography-Forecast(2015-2020)

  • January 2015
  • -
  • Industry ARC
  • -
  • 180 pages

Summary

Table of Contents

Point-of-Care (POC) testing is an immediate testing service performed within close proximity of the patient. Global POC diagnostic devices market has been classified into three segments such as by application, by end user and by technology, providing exhaustive value analysis for the year 2014 and forecast to 2020. This market has been growing at a very rapid pace for the last few years and is projected to grow with a healthy CAGR of 10.65% through 2020 to generate $34 billion.

The North American market followed by Europe account for the largest share in the global POC diagnostic devices market in 2014. It is estimated to grow at a CAGR of 10.01% from 2015 to 2020. Good clinical and economic outcome, increase in aging population and obesity are main factors that are steering the market. The U.S. constitutes a major share in healthcare industry. Majority of POC devices are applicable for chronic diseases and in North America, where nearly 1 in 2 adults live with at least one chronic disease, according to the Centers for Disease Control and Prevention (CDC). The APAC region is poised to grow with the highest CAGR of 11.95% during the forecast period, owing to APAC’s rapidly aging population and higher obesity rates when compared to North America, Europe and rest of the world.

Regular blood glucose monitoring is mandatory for diabetes patients and the majority of POC diabetic testing devices are utilized by them. Patient self-testing dominated the POC diabetic testing devices market in 2014 and also is projected to grow with the highest CAGR through 2020. According to World Health Organization (WHO), the percentage of diabetic patients in the world population was 2.8% in 2000 and it is estimated grow up to 4.4% by 2030. Keeping these factors in mind, the companies which are manufacturing POC devices at least have blood glucose monitoring systems in their product portfolio. Roche point-of-care, Alere Inc., Siemens Health, Bayer Diabetes Care and Abbott point-of-care are the major market share holders for the POC blood glucose analyzers.

Please note: this report requires certain updates. We have all the information available but require 2 business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

  • $ 5000
  • Industry report
  • February 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...

Global In-Vitro Diagnostics (IVD) Market: Analysis and Forecast 2017-2023 (Focus on Product Type, Test Type, Application, and Competitive Landscape)

Global In-Vitro Diagnostics (IVD) Market: Analysis and Forecast 2017-2023 (Focus on Product Type, Test Type, Application, and Competitive Landscape)

  • $ 4999
  • Industry report
  • April 2017
  • by BIS Research

IVD Market expected to increase to $76 billion by 2023, increasing its influence over healthcare spending globally Description In-Vitro diagnostics (IVD) is a broad term which refers to the use of medical ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.